NASDAQ:ACET

Adicet Bio - ACET News Today

$9.15

+0.46 (+5.29%)

(As of 01/31/2023 05:18 PM ET)

Add

Compare

Today's Range: $8.69
▼
$9.27
50-Day Range: $7.63
▼
$20.19
52-Week Range: $7.42
▼
$21.87

Volume: 355,553 shs
Average Volume: 556,693 shs
Market Capitalization: $392.08 million

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: $27.71

Institutional Ownership

Get Adicet Bio News Delivered to You Automatically

ACET Media Mentions By Week

ACET Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

ACET
News Sentiment
▼
0.44

0.72
▲
Average
Medical
News Sentiment

ACET News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

ACET Articles
This Week
▼
4

1
▲
ACET Articles
Average Week

Source

Source	Headline
	Adicet Bio forbes.com - January 26 at 7:18 AM
	Are Medical Stocks Lagging Adicet Bio (ACET) This Year? finance.yahoo.com - January 25 at 3:29 PM
	ACET.C - \| Stock Price & Latest News \| Reuters reuters.com - January 25 at 10:13 AM
	Short Interest in Adicet Bio, Inc. (NASDAQ:ACET) Drops By 6.8% americanbankingnews.com - January 24 at 7:57 AM
	Down -53.98% in 4 Weeks, Here's Why You Should You Buy the Dip in Adicet Bio, Inc. (ACET) finance.yahoo.com - December 30 at 1:09 PM
	Shareholders in Adicet Bio (NASDAQ:ACET) have lost 49%, as stock drops 22% this past week finance.yahoo.com - December 20 at 9:49 AM
	Adicet Bio, Inc. (ACET) Loses 47% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner msn.com - December 14 at 2:10 PM
	Peering Into Adicet Bio's Recent Short Interest msn.com - December 13 at 6:08 PM
	Adicet Bio Shares Fall After Underwhelming Data From Non-Hodgkin's Lymphoma Study finance.yahoo.com - December 12 at 9:07 PM
	Adicet Bio plunges 38% after updating Phase 1 data for blood cancer therapy seekingalpha.com - December 12 at 3:57 PM
	Adicet Bio Plummets After Cancer Drug Trial Disappoints Investors bloomberg.com - December 12 at 3:57 PM
	Adicet Bio Reports Positive Data from Ongoing ADI-001 Phase 1 Trial in Patients with Relapsed or Refractory Aggressive B-Cell Non-Hodgkin’s Lymphoma (NHL) finance.yahoo.com - December 10 at 4:21 PM
	What Makes Adicet Bio, Inc. (ACET) a Good Fit for 'Trend Investing' nasdaq.com - December 7 at 5:44 PM
	Is Adicet Bio (ACET) Stock Outpacing Its Medical Peers This Year? finance.yahoo.com - December 7 at 5:44 PM
	Adicet Bio to Host Investor Webcast to Discuss Updated Clinical Data from Ongoing ADI-001 Phase 1 Trial in Patients with Relapsed or Refractory Aggressive B-Cell Non-Hodgkin’s Lymphoma (NHL) finance.yahoo.com - December 2 at 8:54 AM
	Adicet Bio to Present at the Virtual JMP Securities Hematology and Oncology Summit finance.yahoo.com - November 30 at 5:14 PM
	Wall Street Analysts Think Adicet Bio, Inc. (ACET) Could Surge 72%: Read This Before Placing a Bet finance.yahoo.com - November 29 at 1:12 PM
	Adicet Bio Appoints Nancy Boman, M.D., Ph.D., as Senior Vice President and Chief Regulatory Officer finance.yahoo.com - November 29 at 8:11 AM
	Is Adicet Bio (ACET) Outperforming Other Medical Stocks This Year? msn.com - November 11 at 12:57 PM
	Wall Street Analysts See a 39% Upside in Adicet Bio, Inc. (ACET): Can the Stock Really Move This High? msn.com - November 11 at 12:57 PM
	Adicet Bio Third Quarter 2022 Earnings: US$0.53 loss per share (vs US$0.44 loss in 3Q 2021) finance.yahoo.com - November 11 at 7:56 AM
	Adicet Bio, Inc. (ACET) Reports Q3 Loss, Misses Revenue Estimates msn.com - November 8 at 9:46 PM
	Adicet Reports Third Quarter 2022 Financial Results and Provides Business Updates finance.yahoo.com - November 8 at 4:30 PM
	Adicet Bio Showcases Preclinical Data for Four New Pipeline Programs at The Society for Immunotherapy of Cancer (SITC) 37th Annual Meeting finance.yahoo.com - November 7 at 11:49 AM
	BTIG Keeps Their Buy Rating on Adicet Bio (ACET) markets.businessinsider.com - November 4 at 6:01 AM
	Adicet Bio Reports ASH Abstract Data from Ongoing ADI-001 Phase 1 Trial in Relapsed or Refractory Aggressive B-Cell Non-Hodgkin’s Lymphoma (NHL) finance.yahoo.com - November 3 at 12:10 PM
	Adicet Bio to Present at the 2022 Jefferies London Healthcare Conference finance.yahoo.com - November 1 at 7:10 AM
	Calculating The Intrinsic Value Of Adicet Bio, Inc. (NASDAQ:ACET) finance.yahoo.com - October 23 at 12:30 PM
	A Look At The Intrinsic Value Of Adicet Bio, Inc. (NASDAQ:ACET) nasdaq.com - October 14 at 6:28 PM
	Adicet Bio to Present Preclinical Data from Allogeneic Gamma Delta T Cell Pipeline Programs at The Society for Immunotherapy of Cancer (SITC) 37th Annual Meeting finance.yahoo.com - October 5 at 1:29 PM
	Redwood City biotech adds space exactly where it needed it: 'We just didn't have enough room' bizjournals.com - September 13 at 12:59 PM
	Adicet Bio, Inc. (NASDAQ:ACET) Receives Average Recommendation of "Moderate Buy" from Analysts americanbankingnews.com - September 12 at 6:27 AM
	Despite shrinking by US$93m in the past week, Adicet Bio (NASDAQ:ACET) shareholders are still up 99% over 1 year nasdaq.com - August 16 at 8:42 PM
	The Consensus EPS Estimates For Adicet Bio, Inc. (NASDAQ:ACET) Just Fell Dramatically finance.yahoo.com - August 16 at 10:41 AM
	Adicet Bio, (ACET) Investor Presentation - Slideshow seekingalpha.com - August 14 at 9:59 PM
	Adicet Bio Posts Wider Loss In Q2 nasdaq.com - August 10 at 1:06 PM
	Adicet Bio, Inc. (ACET) Reports Q2 Loss, Misses Revenue Estimates finance.yahoo.com - August 10 at 1:06 PM
	Adicet Bio, Inc. (ACET) Is a Great Choice for "Trend" Investors, Here's Why finance.yahoo.com - July 18 at 11:54 AM
	Adicet Bio updates Phase 1 data for CAR-T candidate in blood cancer seekingalpha.com - June 6 at 11:47 AM
	Adicet Bio Reports Emerging Data from ADI-001 Phase 1 Trial at the American Society of Clinical Oncology Annual Meeting finance.yahoo.com - June 6 at 11:47 AM
	Adicet Bio gains after updating early-stage data for CAR-T therapy in blood cancer seekingalpha.com - May 27 at 11:29 AM
	Adicet Bio Reports Positive Clinical Update from ADI-001 Phase 1 Trial in Relapsed/Refractory Non-Hodgkin’s Lymphoma (NHL) finance.yahoo.com - May 26 at 8:20 PM
	Adicet Bio to Present at Upcoming Investor Conferences finance.yahoo.com - May 18 at 5:09 PM
	Results: Adicet Bio, Inc. Confounded Analyst Expectations With A Surprise Profit finance.yahoo.com - May 15 at 9:42 AM
	Adicet Reports First Quarter 2022 Financial Results and Provides Business Updates finance.yahoo.com - May 13 at 2:06 AM
	Further weakness as Adicet Bio (NASDAQ:ACET) drops 31% this week, taking one-year losses to 17% finance.yahoo.com - May 12 at 3:26 PM
	Adicet Presents Preclinical Data at the ISCT Annual Meeting Highlighting Potential Advantages of the Non-Gene-Edited Approach for its Investigational Allogeneic Gamma Delta CAR T Cell Therapy Targeting CD20 for B Cell Malignancies finance.yahoo.com - May 5 at 8:53 AM
	Adicet Bio Announces Oral Presentation of Updated ADI-001 Phase 1 Data at the 2022 American Society of Clinical Oncology (ASCO) Annual Meeting finance.yahoo.com - April 27 at 10:50 AM
	Adicet Bio stock soars 13% on FDA fast track status for ADI-001 to treat blood cancer seekingalpha.com - April 19 at 9:04 AM
	Adicet Bio's Lead Candidate ADI-001 Gets FDA Fast Track Designation - Quick Facts nasdaq.com - April 19 at 9:04 AM

Get Adicet Bio News Delivered to You Automatically

This page (NASDAQ:ACET) was last updated on 1/31/2023 by MarketBeat.com Staff

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

Adicet Bio - ACET News Today

ACET Media Mentions By Week

ACET Media Sentiment

ACET News Coverage

About MarketBeat

Popular Tools

Financial Calendars

Terms & Info